Organon (OGN) Exchange Rate Effect (2020 - 2026)
Organon (OGN) posted quarterly Exchange Rate Effect of -$31.0 million for Q1 2026, down 170.45% year-over-year from $44.0 million in Q1 2025, and down 338.46% on a QoQ basis from $13.0 million in Q4 2025.
Organon (OGN) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Exchange Rate Effect for 7 consecutive years, with -$31.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 170.45% year-over-year to -$31.0 million; the TTM figure through Mar 2026 stood at $75.0 million (up 1037.5% YoY), while the FY2025 annual figure was $150.0 million, up 297.37% from the prior year.
- Exchange Rate Effect came in at -$31.0 million for Q1 2026 at Organon, down from $13.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $93.0 million in Q2 2025, with the low at -$100.0 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is $1.5 million, with a median of -$7.0 million recorded in 2022.
- Across the five-year window, Exchange Rate Effect plunged 3500.0% in 2022 and surged 504.35% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $83.0 million in 2022, then slumped by 51.81% to $40.0 million in 2023, then slumped by 350.0% to -$100.0 million in 2024, then soared by 113.0% to $13.0 million in 2025, then sank by 338.46% to -$31.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$31.0 million, $13.0 million, and $93.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 67.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -25.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -12.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -18.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -77.00 Mn |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | -31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.00 Mn |
| Mar 31, 2026 | -31.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | -40.00 Mn |
| Sep 30, 2023 | -40.00 Mn |